These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9066476)

  • 1. No sex differences in immunisation rates of British south Asian children: the effect of migration?
    Martineau A; White M; Bhopal R
    BMJ; 1997 Mar; 314(7081):642-3. PubMed ID: 9066476
    [No Abstract]   [Full Text] [Related]  

  • 2. Children who miss immunisation: implications for eliminating measles.
    Evans MR
    BMJ; 1995 May; 310(6991):1367-8. PubMed ID: 7787540
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
    Miller E; Waight P
    BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective cohort study of risk factors for missing preschool booster immunisation.
    Evans MR; Thomas DR
    Arch Dis Child; 1998 Aug; 79(2):141-4. PubMed ID: 9797595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting uptake of measles, mumps, and rubella immunisation.
    Li J; Taylor B
    BMJ; 1993 Jul; 307(6897):168-71. PubMed ID: 8343745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A; Marshall R
    Commun Dis Public Health; 1999 Jan; 2(1):50-3. PubMed ID: 10462897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.
    Roberts RJ; Sandifer QD; Evans MR; Nolan-Farrell MZ; Davis PM
    BMJ; 1995 Jun; 310(6995):1629-32. PubMed ID: 7795447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mumps meningitis following measles, mumps, and rubella immunisation.
    Lancet; 1989 Aug; 2(8659):394-5. PubMed ID: 2569586
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG; White JM; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Measles Control Campaign and immunisation adverse events.
    Burgess MA; Heath TC; McIntyre PB
    Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial.
    Mason BW; Donnelly PD
    Commun Dis Public Health; 2000 Mar; 3(1):67-8. PubMed ID: 10743326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological evaluation of a measles, mumps, and rubella vaccine.
    Robertson CM; Bennett VJ; Jefferson N; Mayon-White RT
    Arch Dis Child; 1988 Jun; 63(6):612-6. PubMed ID: 3291787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revaccination against measles and rubella.
    Cutts FT
    BMJ; 1996 Mar; 312(7031):589-90. PubMed ID: 8595319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.